Polish Academy of Sciences   Report issue

Government Phase 1
Founded: Warsaw Poland (1951)

Organization Overview

First Clinical Trial
2005
NCT00693680
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Mossakowski Medical Research Centre Polish Academy of Sciences | Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences

Active Ingredients

Drugs in Phase 1 Trials (1)

allogeneic adipose derived mesenchymal stem cell (2 trials)

Drugs in Other Trials (1)

zn2+ (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 1)

Drug Resistant Epilepsy (Phase 1)

Epilepsy (Phase 1)

Motor Neuron Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 2